<DOC>
	<DOCNO>NCT02072187</DOCNO>
	<brief_summary>Low level vitamin D associate depression . This study test vitamin D supplement helpful patient depression find relief use anti-depressant medication . Participants continue take medication plus vitamin D placebo 8 week . The investigator monitor depression symptom investigator think people take vitamin D may improvement symptom .</brief_summary>
	<brief_title>Adjunctive Vitamin D Treatment Non-remitted Depression</brief_title>
	<detailed_description>It hypothesize deficient insufficient level vitamin D may play role pathogenesis depression supplemental vitamin D may antidepressant effect -either direct action brain though correction deficiency state . The investigator hypothesize eight week vitamin D supplementation produce statistically significant decrease symptom depression compare placebo people non-remitted depression . This study randomize , double-blind placebo-controlled study . Individuals recruit fail achieve remission depressive episode minimum eight week treatment first-line antidepressant , adequate dose . They randomize receive either placebo vitamin D supplementation addition anti-depressant medication , continue take dose duration eight week study.There additional follow visit one month later . The primary objective evaluate efficacy supplemental vitamin D adjunctive treatment management non-remitted depression compare placebo . Additionally , safety tolerability assess . A secondary objective ass relationship change serum vitamin D level mood order elucidate information role reversal vitamin D deficiency may play treatment condition .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Patients meet follow criterion eligible enrolment trial : 1 . Men Women age 18 65 ( extreme include ) outpatient 2 . Patients primary diagnosis Major Depressive Disorder ( MDD ) accord DSMIVTR criterion ( 16 ) , confirm use Mini International Neuropsychiatric Interview ( MINI ) 3 . Patients fail respond treatment single pharmacological antidepressant agent adequate dose define lack remission current depressive episode ( score 7 less Hamilton Depression Scale ) eight week treatment 4 . On basis physical examination , medical history basic laboratory screening , patient , investigator opinion , suitable condition 5 . Willing able attend study appointment correct time windows Patients meet one follow criterion select inclusion : 1 . Any Axis I disorder primary disorder past 6 month . Comorbid anxiety disorder permit long MDD judge primary diagnosis . 2 . Current past mania hypomania mixed mood disorder phase suggestive bipolar mood disorder define DSMIVTR ( 16 ) 3 . Current past psychotic disorder 4 . Diagnosis mental retardation , dementia cognitive disorder 5 . Current past alcohol drug use define DSMIVTR ( 16 ) last six month 6 . Commencement formal psychotherapy 30 day prior Screening ( formal psychotherapy study purpose include Cognitive Behavioural Therapy ( CBT ) acute CBT treatment individual therapy ) 7 . Current use psychiatric medication antidepressant patient fail show sufficient response . Short halflife hypnotic ( anxiolytic ) allow p.r.n . even treatment insomnia 8 . Patient use herbal nutritional treatment judge antidepressant effect unless discontinue use physician 's consent 2 week prior entry study 9 . Clinical interpretation apparent suicide risk 10 . Supplementation vitamin D &gt; 200IU per day past 6 month 11 . Baseline serum vitamin D &gt; 150nmol/L 12 . A history parathyroid disease kidney stone 13 . Pregnant breastfeeding female 14 . Serious medical illness : Liver renal insufficiency , cardiac , vascular , pulmonary , gastrointestinal , endocrine , neurological , infectious , neoplastic metabolic disturbance , diabetes , dyslipidemia hypertension ; judgment investigator appropriate study medical ground 15 . The patient , opinion investigator , unlikely able comply clinical trial protocol , unsuitable reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Complementary Alternative Medicine</keyword>
	<keyword>Supplements</keyword>
	<keyword>Non Remitted Depression</keyword>
</DOC>